Ashwagandha and Kidney Transplant Rejection
Open Access
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Kidney International Reports
- Vol. 5 (12) , 2375-2378
Abstract
No abstract availableFunding Information
- Department of Medicine, Ottawa Hospital
This publication has 8 references indexed in Scilit:
- Supplement Use by US Adults With CKD: A Population-Based StudyAmerican Journal of Kidney Diseases, 2019
- Cancer immunotherapy in a neglected population: The current use and future of T-cell-mediated checkpoint inhibitors in organ transplant patientsCancer Treatment Reviews, 2018
- Dietary Supplements and Herbal Preparations in Renal and Liver Transplant RecipientsTransplantation Proceedings, 2011
- Herbs and the kidneyAmerican Journal of Kidney Diseases, 2004
- Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with ST JOHN???S wortTransplantation, 2002
- Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review.2000
- Studies on the immunomodulatory effects of AshwagandhaJournal of Ethnopharmacology, 1996
- Immunomodulatory and CNS effects of sitoindosides IX and X, two new glycowithanolides from Withania somniferaPhytotherapy Research, 1989